- Home
- APAM vs CPRX Comparison
APAM vs CPRX Comparison
Compare APAM & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APAM
- CPRX
- Stock Information
- Founded
- APAM 1994
- CPRX 2002
- Country
- APAM United States
- CPRX United States
- Employees
- APAM N/A
- CPRX N/A
- Industry
- APAM Investment Managers
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- APAM Finance
- CPRX Health Care
- Exchange
- APAM Nasdaq
- CPRX Nasdaq
- Market Cap
- APAM 2.9B
- CPRX 2.9B
- IPO Year
- APAM 2013
- CPRX 2006
- Fundamental
- Price
- APAM $40.50
- CPRX $24.96
- Analyst Decision
- APAM Hold
- CPRX Strong Buy
- Analyst Count
- APAM 5
- CPRX 7
- Target Price
- APAM $39.50
- CPRX $32.29
- AVG Volume (30 Days)
- APAM 593.0K
- CPRX 1.1M
- Earning Date
- APAM 07-22-2025
- CPRX 05-07-2025
- Dividend Yield
- APAM 8.81%
- CPRX N/A
- EPS Growth
- APAM 10.09
- CPRX 178.13
- EPS
- APAM 3.64
- CPRX 1.57
- Revenue
- APAM $1,124,598,000.00
- CPRX $534,645,999.00
- Revenue This Year
- APAM $3.53
- CPRX $16.37
- Revenue Next Year
- APAM $5.21
- CPRX $8.80
- P/E Ratio
- APAM $11.08
- CPRX $15.91
- Revenue Growth
- APAM 11.90
- CPRX 29.97
- 52 Week Low
- APAM $32.75
- CPRX $14.75
- 52 Week High
- APAM $49.54
- CPRX $26.16
- Technical
- Relative Strength Index (RSI)
- APAM 50.60
- CPRX 59.49
- Support Level
- APAM $40.27
- CPRX $23.76
- Resistance Level
- APAM $41.56
- CPRX $25.00
- Average True Range (ATR)
- APAM 0.90
- CPRX 0.72
- MACD
- APAM -0.30
- CPRX 0.05
- Stochastic Oscillator
- APAM 10.30
- CPRX 86.76
About APAM Artisan Partners Asset Management Inc.
Artisan Partners Asset Management Inc is a global investment management firm providing a range of investment strategies to a diverse group of clients around the world. Each of the company's strategies is managed by one of its several investment teams. Investment management services are primarily offered to institutions through separate accounts and mutual funds. Artisan's investment offerings include several long-only, equity investment strategies across a multitude of market capitalization segments and investing styles in both the United States and international markets. In addition to its equity strategies, customers may invest in a fixed-income strategy. Strategies are often distributed to customers ranging from retail investors to institutional investors through specialized channels.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).